Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial

Autor: Soin, Arvinder S *, Kumar, Kuldeep, Choudhary, Narendra S, Sharma, Pooja, Mehta, Yatin, Kataria, Sushila, Govil, Deepak, Deswal, Vikas, Chaudhry, Dhruva, Singh, Pawan Kumar, Gupta, Ashish, Agarwal, Vikas, Kumar, Suresh, Sangle, Shashikala A, Chawla, Rajesh, Narreddy, Suneetha, Pandit, Rahul, Mishra, Vipul, Goel, Manoj, Ramanan, Athimalaipet V
Zdroj: In The Lancet Respiratory Medicine May 2021 9(5):511-521
Databáze: ScienceDirect